PT83052B - Processo para a preparacao de composicoes farmaceuticas de libertacao controlada a base de um sal de adicao de acido ou de amonio quaternario, de um polimero e de um agente tensio-activo - Google Patents

Processo para a preparacao de composicoes farmaceuticas de libertacao controlada a base de um sal de adicao de acido ou de amonio quaternario, de um polimero e de um agente tensio-activo

Info

Publication number
PT83052B
PT83052B PT83052A PT8305286A PT83052B PT 83052 B PT83052 B PT 83052B PT 83052 A PT83052 A PT 83052A PT 8305286 A PT8305286 A PT 8305286A PT 83052 B PT83052 B PT 83052B
Authority
PT
Portugal
Prior art keywords
polymer
ammonium
stress
preparation
pharmaceutical compositions
Prior art date
Application number
PT83052A
Other languages
English (en)
Other versions
PT83052A (en
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of PT83052A publication Critical patent/PT83052A/pt
Publication of PT83052B publication Critical patent/PT83052B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT83052A 1985-07-26 1986-07-24 Processo para a preparacao de composicoes farmaceuticas de libertacao controlada a base de um sal de adicao de acido ou de amonio quaternario, de um polimero e de um agente tensio-activo PT83052B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8511575A FR2585246A1 (fr) 1985-07-26 1985-07-26 Procede d'obtention de formes pharmaceutiques solides a liberation prolongee

Publications (2)

Publication Number Publication Date
PT83052A PT83052A (en) 1986-08-01
PT83052B true PT83052B (pt) 1988-07-01

Family

ID=9321740

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83052A PT83052B (pt) 1985-07-26 1986-07-24 Processo para a preparacao de composicoes farmaceuticas de libertacao controlada a base de um sal de adicao de acido ou de amonio quaternario, de um polimero e de um agente tensio-activo

Country Status (13)

Country Link
US (1) US4834965A (pt)
EP (1) EP0214735B1 (pt)
AT (1) ATE66599T1 (pt)
AU (1) AU585377B2 (pt)
CA (1) CA1304684C (pt)
DE (1) DE3681099D1 (pt)
DZ (1) DZ964A1 (pt)
ES (1) ES2000555A6 (pt)
FR (1) FR2585246A1 (pt)
MA (1) MA20745A1 (pt)
OA (1) OA08368A (pt)
PT (1) PT83052B (pt)
ZA (1) ZA865455B (pt)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
EP0856313A1 (en) * 1987-10-16 1998-08-05 ELAN CORPORATION, Plc Controlled absorption diltiazem formulations
EP0406315B1 (en) * 1988-03-24 1992-11-11 Bukh Meditec A/S Controlled release composition
FR2630913A1 (fr) * 1988-05-09 1989-11-10 Delalande Sa Comprimes de sel(s) hydrosoluble(s) de diltiazem a liberation programmee et leur procede de fabrication
DE3931215C2 (de) * 1988-09-20 1998-07-16 Glaxo Group Ltd Pharmazeutische Präparate auf der Grundlage von Ranitidin
EP0557064B1 (en) * 1992-02-20 1997-06-11 Euroceltique S.A. Modified release formulation
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
WO1995013798A1 (en) * 1993-11-18 1995-05-26 Cancer Research Institute Inc. Controlled release preparation
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5419917A (en) * 1994-02-14 1995-05-30 Andrx Pharmaceuticals, Inc. Controlled release hydrogel formulation
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
WO1997037680A1 (en) * 1996-04-05 1997-10-16 The Board Of Trustees Of The University Of Illinois Macromolecular complexes for drug delivery
US6057367A (en) 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
US5935599A (en) * 1996-10-28 1999-08-10 The Board Of Trustees Of The University Of Illinois Polymer-associated liposomes for drug delivery and method of manufacturing the same
HUP0100310A3 (en) * 1997-12-22 2002-11-28 Euro Celtique Sa A method of preventing abuse of opioid dosage forms
TR200001942T2 (tr) 1997-12-22 2000-11-21 Euro-Celtique, S.A. Opioid agonist/antagonist kombinasyonlar
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20060034937A1 (en) * 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
EP2092936B1 (en) 2000-02-08 2013-03-20 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6417237B1 (en) * 2000-06-08 2002-07-09 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes and compositions containing the same
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
US6855721B1 (en) 2000-07-28 2005-02-15 Indevus Pharmaceuticals, Inc. Methods and compositions for alleviating stuttering
JP4522652B2 (ja) 2001-05-11 2010-08-11 エンドー ファーマシューティカルズ， インコーポレイティド 乱用防止制御放出オピオイド投薬形態
IL159917A0 (en) * 2001-07-18 2004-06-20 Euro Celtique Sa Pharmaceutical combinations of oxycodone and naloxone
MXPA04001210A (es) 2001-08-06 2004-07-08 Euro Celtique Sa Formulaciones de agonista opioide con antagonista liberable y aislado.
WO2003013433A2 (en) * 2001-08-06 2003-02-20 Euro-Celtique S.A. Sequestered antagonist formulations
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
EP2425821B1 (en) 2002-04-05 2017-05-10 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
AU2003272601B2 (en) * 2002-09-20 2009-05-07 Alpharma Pharmaceuticals, Llc Sustained-release opioid formulations and methods of use
US7815934B2 (en) * 2002-09-20 2010-10-19 Alpharma Pharmaceuticals, Llc Sequestering subunit and related compositions and methods
US20040192781A1 (en) * 2003-03-31 2004-09-30 Haley Eugene T. Method of administration for metoclopramide and pharmaceutical formulation therefor
US20050137265A1 (en) * 2003-03-31 2005-06-23 Haley Eugene T. Rapidly dissolving metoclopramide solid oral dosage and method thereof
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
MY135852A (en) * 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
US8906413B2 (en) 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
EP1694128A4 (en) * 2003-12-18 2007-04-18 Huntsman Spec Chem Corp PESTICIDE GRANULATE WITH IMPROVED SURFACE WITH RASCHER ACTIVE SUBSTANCE
AU2005237607B2 (en) 2004-04-27 2010-12-16 Medicinova, Inc. Phenoxyalkycarboxylic acid derivatives in the treatment of inflammatory diseases
AU2005244401B2 (en) * 2004-05-14 2009-01-22 Green Cross Corp. Neuroprotective properties of dextrorotatory morphinans
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
AU2005295482B2 (en) * 2004-10-15 2011-03-31 Supernus Pharmaceuticals Inc. Less abusable pharmaceutical preparations
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
CA2606740A1 (en) * 2005-05-03 2006-11-09 Mutual Pharmaceutical Company, Inc. Quinine-containing controlled-release formulations
WO2007056205A2 (en) * 2005-11-04 2007-05-18 Eastman Chemical Company Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
MX2008016372A (es) 2006-06-19 2009-05-28 Alpharma Inc Composiciones farmaceuticas.
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
AU2009268011B2 (en) * 2008-07-07 2013-02-28 Mundipharma Pty Limited Use of opioid antagonists for treating urinary retention
AU2009332963B2 (en) * 2008-12-31 2015-02-05 Upsher-Smith Laboratories, Llc Opioid-containing oral pharmaceutical compositions and methods
US11304960B2 (en) * 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
HUE042105T2 (hu) 2009-03-10 2019-06-28 Euro Celtique Sa Oxikodont és naloxont tartalmazó azonnali hatóanyagleadású orális gyógyászati készítmények
BR112012008317A2 (pt) 2009-09-17 2016-03-22 Upsher Smith Lab Inc produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US8835499B2 (en) 2011-12-08 2014-09-16 Medicinova, Inc. Method of treating non-alcoholic fatty liver disease and steatohepatitis
US8962687B2 (en) 2012-12-05 2015-02-24 Medicinova, Inc. Method of treating liver disorders
EP3024461B1 (en) 2013-07-23 2020-05-13 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
CA2917780C (en) 2013-07-25 2023-01-24 Medicinova, Inc. Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
US20150321989A1 (en) 2014-05-08 2015-11-12 Medicinova, Inc. Method of treating idiopathic pulmonary fibrosis
US9346754B2 (en) 2014-05-08 2016-05-24 Medicinova, Inc. Method of treating advanced non-alcoholic steatohepatitis
US9498458B2 (en) 2014-06-02 2016-11-22 Medicinova, Inc. Method of inhibiting or treating fibrosis
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
KR102462638B1 (ko) 2014-11-26 2022-11-03 메디시노바, 인크. 이부딜라스트와 릴루졸의 배합물 및 이의 사용방법
EP3364955B1 (en) 2015-10-09 2022-04-20 RB Health (US) LLC Pharmaceutical formulation
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
CN117320701A (zh) 2021-05-28 2023-12-29 美迪诺亚公司 一种降低肝脏中甘油三酯合成的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2802114A1 (de) * 1978-01-19 1979-07-26 Sandoz Ag Neue pharmazeutische zusammensetzung und verfahren zu deren herstellung
FR2523446A1 (fr) * 1982-03-19 1983-09-23 Dietlin Francois Nouveau procede d'obtention de formes pharmaceutiques a liberation programmee
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
US4624848A (en) * 1984-05-10 1986-11-25 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release

Also Published As

Publication number Publication date
EP0214735A1 (en) 1987-03-18
AU6058386A (en) 1987-01-29
OA08368A (fr) 1988-02-29
MA20745A1 (fr) 1987-04-01
CA1304684C (en) 1992-07-07
AU585377B2 (en) 1989-06-15
DZ964A1 (fr) 2004-09-13
US4834965A (en) 1989-05-30
ZA865455B (en) 1987-03-25
DE3681099D1 (de) 1991-10-02
ATE66599T1 (de) 1991-09-15
FR2585246A1 (fr) 1987-01-30
EP0214735B1 (en) 1991-08-28
ES2000555A6 (es) 1988-03-01
PT83052A (en) 1986-08-01

Similar Documents

Publication Publication Date Title
PT83052B (pt) Processo para a preparacao de composicoes farmaceuticas de libertacao controlada a base de um sal de adicao de acido ou de amonio quaternario, de um polimero e de um agente tensio-activo
DE3574931D1 (de) Verfahren und anlage zur herstellung von sterilem wasser und sterilen waessrigen loesungen.
BR8903252A (pt) Processo para producao de um copolimero de siloxano com amonio quaternario pendente
BR8702172A (pt) Processo para preparacao de estrutura de difluoreto de polivinilideno,estrutura de difluoreto de polivinilideno e membrana microporosa de difluoreto de polivinilideno
NO970732D0 (no) Ultrasoniske kontrastmidler, fremgangsmåte ved fremstilling derav samt deres anvendelse som diagnostiske midler
PT88252A (pt) Processo para a preparacao de um produto, para banho de chuveiro, em forma de gel, contendo como parte integrante da estrutura do gel um agente de formacao de espuma de hidrocarboneto alifatico saturado
BR8805440A (pt) Processo para a fabricacao de 1,1,1-trifluorodicloroetano e/ou 1,1,1,2-tetrafluorocloroetano por fluoracao de um tetrahaloetileno
IT8821481A0 (it) Processo ed apparato per la devolatilizzazione di soluzioni di polimeri.
BR8304500A (pt) Processo para a preparacao de gel aquoso refrescante de ar e gel refrescante de ar
DK0457660T3 (da) Absorberende polymere, fremgangsmåde til deres fremstilling samt deres anvendelse
BR8904716A (pt) Composicao aquosa,processo para a producao de compostos e metodo de tratamento de um sistema aquoso
BR8802853A (pt) Resinas permutadoras de ions,processo para sua preparacao,utilizacao e medicamentos
ES2029853T3 (es) Un metodo para preparar una base para pomada de gel.
BR8701045A (pt) Processo para a elaboracao de solucoes de amina aquosas
BR8701149A (pt) Eixo de acionamento,processo e dispositivo para a fabricacao do eixo de acionamento
BR8804494A (pt) Processo para a producao de metanol,sistema catalitico para a producao de metanol e metanol
BR8803697A (pt) Processo para a preparacao de um polimero hidrogenado funcionalizado e copolimero funcionalizado
BR8704541A (pt) Formulacao de espuma de poliuretano,sistema agente de ligacoes cruzadas e processo para fabricacao de espumas de poliuretano
PT84821B (pt) Processo para a preparacao de uma composicao aquosa de fenol sulfonato,uma amina e um sal de curtimento, utilizada como agente de curtimento
PT90176A (pt) Processo para a preparacao de um agente de tratamento de gado equideo
BR8905836A (pt) Interface para utilizacao em um meio fisico de sistema de computador entre um ou mais programas de aplicacao,processo para utilizacao em um meio fisico de sistema de computador para interfacear um ou mais programas de aplicacao e interface de protocolo aberto para utilizacao em um meio fisico de sistema de computador que suporta a transmissao de mensagens de interaplicacao e os servicos de dialogo por programas de aplicacao
BR7903320A (pt) Dispersao aquosa de plastico a base de um polimero de ester vinilico,processo para a sua producao,e agente de pintura preparado a partir da mesma
BR8706286A (pt) Processo para preparacao de composto,sistema catalitico e processo para producao de poliolefina
PT90530A (pt) Processo para a preparacao de derivados do acido 1,1-dioxo-cefem-4-carbotiolico e de composicoes farmaceuticas ou veterinarias que os contem
BR8701478A (pt) Mistura de aclaradores oticos,aplicacao e agente para o aclaramento otico de fibras